In this paper we analyze the cross-sectional relationship between hospital quality scores calculated by the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) and risk-adjusted indicators of outcomes and quality-mortality, rates of surgical/medical misadventures, adverse drug reactions, and length of stay-calculated from Nationwide Inpatient Sample discharge records. The results suggest that greater adherence to JCAHO accreditation standards is not associated with reduced mortality or lower probability of avoidable hospital or physician-caused adverse outcomes. Other hospital characteristics, such as teaching/nonteaching and urban/rural status, also exhibit little or no correlation with risk-adjusted survival and adverse-event probabilities.
Introduction
The interest among purchasers in managed care enrollment in the United States over the last decade has brought with it both excitement and debate. Earlier in the decade, purchasers were enthusiastic about the ability of managed care to contain costs and arrest the rate of growth in spending. Indeed between 1990 and 1997, the rate of health expenditures declined from 12.2 percent to 4.8 percent and the rate of growth in private insurance premiums declined from 4.0 percent to 3.2 percent (Levit et al. 1998) . Most analysts attribute the decline to managed care.
However, in recent years the enthusiasm over managed care has waned and has been replaced partially by the concern that enrollment in managed care plans will lead to a decrease in the quality of care. A concern over the quality of care that managed care plans deliver was one of the motivations that led to the development of the National Committee on Quality Assurance (NCQA) and in turn to HEDIS. Worries over managed care, the heavy participation of Medicare and Medicaid in managed care and continuous cuts in both programs have fueled a heated and more generalized concern that belt tightening and cost cutting in health care will lead to poorer quality. Several recent studies provide illustrations of the seriousness of the quality concerns.
First, an Institute of Medicine Committee reported that thousands of deaths were linked to medical errors, more deaths than are attributable to breast cancer, traffic accidents and AIDS (Washington Post November 30, 1999) . The IOM report, among other things, called for mandatory disclosure of adverse events by hospitals. In that spirit, a Veteran's Administration report just revealed that almost 3000 medical mistakes occurred during the period June 1997 to December 1998 with 700 of them resulting in deaths (New York Times, December 20, 1999 , front 2 page). Recently, United Health Care a large and one of the most respected managed care companies in the United States announced that it would no longer require gatekeepers to approve referrals to specialists because of widespread concerns that financial incentives impede referrals that are beneficial to patient health. Also, in response to a July 1999 study, The External Review of Hospital Quality, conducted by the Inspector General of the Department of Health and Human Services, Health Care Financing Administration Administrator Nancy Ann Min-DeParle states:
We will hold the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and the state survey agencies more fully accountable for their performance. For example, in our revised Conditions of Participation regulations, we will more clearly define our priorities for hospital surveys of basic health and safety issues such as medication errors and surgery mix-ups. We will also clarify JCAHO's responsibility in monitoring the performance of accredited hospitals and work with them to conduct more unannounced surveys and perform more rigorous assessments of each hospital's internal quality assurance process.
Though HEDIS and other report card approaches to monitoring and insuring quality have been developed only recently, voluntary accreditation of hospitals and other healthcare organizations as a way of assuring a minimal quality standard has been around since 1951. The Joint Commission on the Accreditation of Healthcare Organization is arguably the best known accrediting body in health care today. Hospitals who wish to be reimbursed by Medicare must stand for JCAHO accreditation or certification by their own state; 20 percent of all hospitals fail accreditation by either organization (Inspector General 1999 ). Yet, though JCAHO accreditation is widely accepted, it has never been subjected to empirical scrutiny. In particular, though JCAHO accreditation is supposed to lead to either a minimum level of or an improvement in quality in comparison to what might have existed without accreditation, there are no studies that investigate the relationship between accreditation and quality in order to determine how it is working. This paper has as its goal trying to understand the determinants of several measures of quality of care focussing particularly on whether JCAHO accreditation has a positive impact on the quality/outcomes we can measure. In particular, we estimate the statistical relationships across hospitals among measures of compliance with JCAHO accreditation standards (the overall JCAHO score and performance on the 45 subcategories), patient and hospital characteristics, and several hospital-specific measures of outcome which are thought to be correlated with quality: death, the probability of accidental poisonings, surgical/medical misadventures, adverse drug reactions and length of stay. In the following sections we discuss our data sources, hypotheses, estimation strategy, findings and conclusions. The reader should keep in mind that our results are very preliminary and that, as we explain below, much work remains to be done both in the measurement of several variables and in our econometric specification.
Previous Literature
Through the years there have been many studies of three determinants of hospital based outcomes death, cost and length of stay; they are too numerous to summarize in this paper. More recently there has emerged a small and growing literature on the determinants of hospital quality.
While many of the newer articles on hospital quality still use measures of death as the dependent variable, they address two important problems that earlier articles on hospital outcome determinants did not.
First economists focused first on whether hospital characteristics such as teaching status and volume are associated with death rates and outcomes for specific diseases such as acute myocardial infarction. The authors of these newer studies correctly point out the need to model patient severity very carefully (see for example, McClellan et al. 1994; Vaccarino et al. 1999; Thiemann et al. 1999) . Without appropriate clinical variables as controls, there is omitted variable bias that leads to inaccurate conclusions about the relationship between hospital characteristics and dependent measures of quality. Even newer research concentrates principally 4 on how selection issues at the hospital level may introduce biases that may lead to inappropriate conclusions about the measured impact of hospitals on the probability of death. In particular, the focus of the econometrics is on the hypothesis that sicker patients may select hospitals that either offer more specialized procedures or provide higher volumes of certain types of more specialized care that is relevant to a patient's condition. Failure to control for this type of selection bias may lead to under or overestimates of the impact of relevant hospital characteristics such as volume or teaching status on measures of hospital quality. For example, in an important new paper entitled "Measuring Hospital Quality," Tay (1999) uses data on deaths from acute myocardial infarction as a proxy for quality in her exploration of quality differences across hospitals. She points out that patients may choose hospitals based on their health status, so that certain hospitals have sicker patients. Neglecting to control for such unobserved heterogeneity results in unmeasured selection bias with the result that measures of quality do not accurately capture the true effect of a given hospital on the probability of survival. Tay's patient data are reimbursed claims on all non-HMO Medicare beneficiaries from the states of California, Oregon and Washington. She finds that " selection does lead to a correlation between the patient's initial health status and hospital inputs, as measured by the characteristics of the hospital."
In similar research to Tay's, Gowrisankaran and Town (1999) [hereafter G-T] , discuss the fact that discharge databases do not include rich enough data on severity to make appropriate severity adjustments. Since they recognize that it is often too expensive to collect additional information on clinical patient characteristics that could be merged into discharge data, they suggest an instrumental variables method to correct for selection bias in hospital mortality figures. Like Tay, their concern is that "hospitals may differ in the severity of illness of the patients that they treat, as higher quality hospitals may attract a sicker patient population. Thus mortality rates for a hospital will have at least two components: one component that reflects the severity of illness of the patients they treat and the other component that reflects the quality of 5 care they provide. In econometric terms, if a patient's choice of hospital is correlated with his/her (unobserved) severity, then patient choice will be endogenous and any analysis will give inconsistent estimates of the hospital specific contribution to mortality." To address the problem of unobserved heterogeneity, G-T implement instrumental variables estimation using distance of the patient from the hospital as the instrument. They implement their IV model using discharge abstract data provided by the State of California, Office of Statewide Health Planning and Development (OSHPD) on all patients with pneumonia hospitalized between 1989-1994. The OSHPD data include constructed disease-staging which are used as controls. G-T, instrumental estimates provide support for the notion that that failing to correct for unobserved severity leads to bias in measuring hospital mortality.
Even with these recent econometric improvements in the hospital quality literature, there are few if any articles that address more specific quality-related hospital measures such as adverse drug reactions, and medical/surgical misadventures. Lack of attention to other measures of hospital quality is unfortunate. Most patients do not die as a result of hospital care but they are injured in hospitals in ways that often are irreparable. Yet, these types of bad outcomes are almost entirely preventable, making them excellent proxies for hospital quality. Whether the dependent measure in studies of hospital quality has been more widely analyzed (such as is the case with death, cost and length of stay), or rarely investigated (adverse drug reactions and medical misadventures), economists and other researchers apparently have never specifically addressed the impact of hospital accreditation on these variables. The existing studies which attempt to address the relationship between accreditation and measures of adverse outcomes have been more qualitative in nature and have not included empirical analyses; see for example, Gaynes and Solomon (1996) , Young, Charnes, Desai et. al. (1997) and Wolfe (1999) . Indeed an extensive medline search revealed only one empirical article focusing on the relationship between accreditation and any measure of adverse outcome. In addition, there are no more 6 general empirical studies of the determinants of adverse hospital outcomes that we could find. In the one existing study of adverse events (medical misadventures, complications, adverse drug reactions) we could find, Hunter and Bains (1999) used administrative data on hospital admissions and day surgeries in Ontario, Canada, to investigate the correlation with these measures of hospital quality. Hunter and Bains made no attempt to control for patient (including severity) or hospital characteristics and did not investigate the interrelationships among adverse events and time, age and gender. They found increasing rates in all measures of adverse events over time.
In our very preliminary study, we attempt to address two important holes in the literature.
First, in addition to death and length of stay, we look at several other quality-related measures of hospital outcomes. This is important since more individuals who are hospitalized do not die but can experience unexpected consequences as a result of their hospital stay. Second, we analyze what role, if any, JCAHO accreditation plays in reducing poor outcomes. We start by simply using common and older econometric techniques. It is our plan to introduce measures of volume and to better control for selection bias and patient severity in later enhancements.
Data, Hypotheses and Estimation Procedures
Our data set represents the merger of information included on the Hospital Performance of the 938 HCUP-3 hospitals, but we have no reason to suspect that the merged sample is unrepresentative (we address this issue below in our discussion of Table 2 ).
We hypothesize that the higher the overall accreditation summary score, the less likely is death, the shorter is the length of stay, and the lower the probability of a patient experiencing any of the adverse outcomes we measure. [In our analyses, in addition to testing the overall score variable, we also look at the impact of the score in each of the performance areas on death, cost and adverse outcomes. In addition to the accreditation score, we include a number of other independent variables in order to attempt to understand the determinants of outcomes. The other independent variables include vectors of variables representing individual patient characteristics, the characteristics of the hospital, and location and region of the country in which the hospital is located. The patient specific variables include: age (single year-of-age dummies), race (white, black, Hispanic, Asian/Pacific Islander, Native-American, other), gender (male 0 and female 1), the number of diagnoses, the principal diagnosis, the number of procedures performed on the patient, and the payer (Medicare, Medicaid, Blue Cross Blue Shield or BC/BS PPO, Commercial Insurance or Commercial PPO, an HMO or other type of managed care organization or self pay). Measures of diagnoses and procedures are our controls for severity. The hospital specific variables include: bedsize (small, medium, large), hospital control (government, private-non profit, investorowned), and an indicator for whether the hospital had a teaching program (1) or not (0). Finally, we included regressors for region of the country (Northeast, Midwest, South, West), an indicator for rural (0) or urban (1) location, and the average income of the zipcode in which the hospital was located, meant as a proxy for patient income. Ceteris paribus, we would expect that greater severity is positively associated with a higher probability of death or any measure of adverse outcome. We hypothesize patients hospitalized in teaching hospitals would have fewer adverse events and a lower probability of death unless there are unmeasured severity factors, and that non-profit hospitals would outperform the others. We had no specific hypotheses about the other independent variables.
Our dependent variables, all taken from H-CUP3, are all binary except for length of stay.
They are: ANY (measures the probability that ANY of the complications was found on the discharge abstract:), accidental poisoning by a drug, an adverse drug reaction, the probability of a medical/surgical misadventure, and inpatient death. Length of stay is continuous and 10 transformed into natural logarithms. All regressions were estimated in SAS using the General Linear Models procedure. Table 1 includes a list of definitions of the dependent and independent variables; in Table 2 we present minima, maxima and mean. Table 3 presents the regressions for each of the dependent variables. Note that the regressor of most interest is SCORE, whose coefficient indicates the estimated relationship between the overall JCAHO score and the dependent variable. In the interest of focus and space we present in Table 3 only our estimates of the most interesting relationships. The full regressions are available from the authors. Table 2 indicates that there are few differences between our merged sample that includes 204 hospitals and the 938 in the full HCUP-3 database. There is a slightly larger fraction of patients in the HCUP-3/JCAHO sample who are in the self-pay category and a slightly smaller percentage in the commercial category. Also, there is about a one percentage point difference in that the merged sample has a higher proportion of blacks than the full HCUP sample. Most importantly, there are no large differences in the dependent variables. Since both samples include millions of discharges, all differences are statistically significant.
Results
We find that our regressions fit reasonably well, especially for cross sectional data (R-squared in the range 0.13 to 0.27-see Table 3 ). However, our hypothesis that a higher JCAHO score will lead to a high probability of survival or lower probability of poor outcomes is not confirmed in any of our regressions. Recall that a higher number indicates a better overall score so that a positive coefficient indicates the greater likelihood of an adverse outcome. In fact, the coefficients were all positive and significant indicating that the probability of an accidental poisoning, surgical/medical misadventure, an adverse drug reaction or death all increased as the SCORE increased. However, the coefficient on score in the LOS equation did support our hypothesis that greater compliance with accreditation standards lowers length of stay.
Our proxies for severity performed as expected. We included fixed diagnosis effects (for the patient's first-listed diagnosis), as well as the total number of diagnoses recorded and procedures performed. For this reason we report the significance of the group of variables (see F test and p-values in Table 3 ). More diagnoses are associated with a greater probability of experiencing any of the complications and of the adverse outcomes. More diagnoses also are associated with an increased length of stay and each construct of variables is highly significant.
Similarly, more procedures and increasing age are associated with a greater probability of occurrence of any of the outcomes and increasing length of stay. Turning to the hospital-level variables of interest, we note that for all the dependent variables except for accidental poisonings and death, non-teaching hospitals are associated with lower probabilities of adverse outcomes. As we suggest above, this result would not be expected unless there are unobserved severity factors that are endogenous to hospital choice not accounted for in our regressions-a problem we suspect. The coefficients on region of the country indicate that hospitals located in the west have statistically significant shorter lengths of stay than any of the other regions of the country. This result provides face validity to our other findings in that it corroborates virtually all other studies that control for region in length of stay regressions.
However, none of the regions consistently outperform others for the other dependent variables.
Similarly, the coefficients on ownership do not indicate a consistent picture. Neither for-profit, non-profit nor governmental hospitals are consistently associated with reductions in adverse outcomes. And contrary to several other studies, individuals who are black do not have a consistently higher probability of death or any of the other outcome measures. Also, none of the payment variables are associated all the time with better outcomes.
Conclusions
This is a first attempt to do two important things: assess the impact of compliance with JCAHO accreditation on two standard measures of hospital quality and performance, death and length of stay, and explore the determinants of three other hospital-related measures of quality not yet analyzed in the literature: the probability of accidental poisonings, surgical/medical misadventures, and adverse affects of drugs. Our results are highly preliminary and should be viewed with appropriate caution. However, the results suggest that whatever adherence to JCAHO accreditation does, it does not lead to greater survival or a lower probability of avoidable hospital or physician-caused adverse outcomes. Similarly, we could not identify any other hospital characteristics that are consistently associated with the likelihood of increased survival, lessened occurrence of adverse outcomes or shorter lengths of stay.
These preliminary findings are highly policy relevant. With much fanfare and press coverage, the IOM released its findings that an unacceptably large number of medical errors are taking place in hospitals, and that national reporting standards and active clinical interventions were needed to address the issue. Also, the Inspector General of DHHS is concerned that not enough attention is being paid to poor quality in unaccredited hospitals in State and JCAHO review processes. Assuming our results hold, the HCFA administrator appears correct in calling for greater accountability by JCAHO. If our results are corroborated after introducing improved measures of severity and after controlling for unobserved heterogeneity, we will have to devise new and better ways to improve the quality of hospital care. 
